Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Immunohistochemical evaluation of ERG expression in various benign and malignant tissues.

Liu H, Shi J, Wilkerson M, Yang XJ, Lin F.

Ann Clin Lab Sci. 2013 Winter;43(1):3-9.

PMID:
23462600
[PubMed - indexed for MEDLINE]
2.

Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.

He H, Osunkoya AO, Carver P, Falzarano S, Klein E, Magi-Galluzzi C, Zhou M.

BJU Int. 2012 Dec;110(11 Pt B):E751-5. doi: 10.1111/j.1464-410X.2012.11557.x. Epub 2012 Oct 9.

PMID:
23046279
[PubMed - indexed for MEDLINE]
3.

ERG expression and prostatic adenocarcinoma.

Verdu M, Trias I, Roman R, Rodon N, Garcia-Pelaez B, Calvo M, Dominguez A, Banus JM, Puig X.

Virchows Arch. 2013 Jun;462(6):639-44. doi: 10.1007/s00428-013-1415-3. Epub 2013 May 24.

PMID:
23703293
[PubMed - indexed for MEDLINE]
4.

The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.

Yaskiv O, Zhang X, Simmerman K, Daly T, He H, Falzarano S, Chen L, Magi-Galluzzi C, Zhou M.

Am J Surg Pathol. 2011 Jul;35(7):1062-8. doi: 10.1097/PAS.0b013e318215cc03.

PMID:
21623182
[PubMed - indexed for MEDLINE]
5.

Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies.

Tomlins SA, Palanisamy N, Siddiqui J, Chinnaiyan AM, Kunju LP.

Arch Pathol Lab Med. 2012 Aug;136(8):935-46. doi: 10.5858/arpa.2011-0424-OA.

PMID:
22849743
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate.

Green WM, Hicks JL, De Marzo A, Illei PP, Epstein JI.

Hum Pathol. 2013 Sep;44(9):1895-901. doi: 10.1016/j.humpath.2013.02.019. Epub 2013 May 9.

PMID:
23664537
[PubMed - indexed for MEDLINE]
7.

The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".

He H, Magi-Galluzzi C, Li J, Carver P, Falzarano S, Smith K, Rubin MA, Zhou M.

Am J Surg Pathol. 2011 Apr;35(4):608-14. doi: 10.1097/PAS.0b013e31820bcd2d.

PMID:
21383613
[PubMed - indexed for MEDLINE]
8.

Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.

Mosquera JM, Perner S, Genega EM, Sanda M, Hofer MD, Mertz KD, Paris PL, Simko J, Bismar TA, Ayala G, Shah RB, Loda M, Rubin MA.

Clin Cancer Res. 2008 Jun 1;14(11):3380-5. doi: 10.1158/1078-0432.CCR-07-5194.

PMID:
18519767
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions.

Cerveira N, Ribeiro FR, Peixoto A, Costa V, Henrique R, Jerónimo C, Teixeira MR.

Neoplasia. 2006 Oct;8(10):826-32.

PMID:
17032499
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application.

Park K, Chiu YL, Rubin MA, Demichelis F, Mosquera JM.

Hum Pathol. 2013 Oct;44(10):2282-92. doi: 10.1016/j.humpath.2013.05.010. Epub 2013 Jul 12.

PMID:
23856515
[PubMed - indexed for MEDLINE]
11.

ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis.

Gao X, Li LY, Zhou FJ, Xie KJ, Shao CK, Su ZL, Sun QP, Chen MK, Pang J, Zhou XF, Qiu JG, Wen XQ, Yang M, Bai XZ, Zhang H, Ling L, Chen Z.

Clin Cancer Res. 2012 Aug 1;18(15):4163-72. Epub 2012 Jun 13.

PMID:
22696228
[PubMed - indexed for MEDLINE]
Free Article
12.

The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.

Quick CM, Gokden N, Sangoi AR, Brooks JD, McKenney JK.

Hum Pathol. 2010 Aug;41(8):1145-9. doi: 10.1016/j.humpath.2010.01.010. Epub 2010 Apr 22.

PMID:
20413145
[PubMed - indexed for MEDLINE]
13.

Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.

Chaux A, Albadine R, Toubaji A, Hicks J, Meeker A, Platz EA, De Marzo AM, Netto GJ.

Am J Surg Pathol. 2011 Jul;35(7):1014-20. doi: 10.1097/PAS.0b013e31821e8761.

PMID:
21677539
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.

van Leenders GJ, Boormans JL, Vissers CJ, Hoogland AM, Bressers AA, Furusato B, Trapman J.

Mod Pathol. 2011 Aug;24(8):1128-38. doi: 10.1038/modpathol.2011.65. Epub 2011 Apr 15.

PMID:
21499236
[PubMed - indexed for MEDLINE]
Free Article
15.

TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

Park K, Dalton JT, Narayanan R, Barbieri CE, Hancock ML, Bostwick DG, Steiner MS, Rubin MA.

J Clin Oncol. 2014 Jan 20;32(3):206-11. doi: 10.1200/JCO.2013.49.8386. Epub 2013 Dec 2.

PMID:
24297949
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.

Zeng L, Rowland RG, Lele SM, Kyprianou N.

Hum Pathol. 2004 Mar;35(3):290-7.

PMID:
15017584
[PubMed - indexed for MEDLINE]
17.

Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.

Furusato B, Gao CL, Ravindranath L, Chen Y, Cullen J, McLeod DG, Dobi A, Srivastava S, Petrovics G, Sesterhenn IA.

Mod Pathol. 2008 Feb;21(2):67-75. Epub 2007 Dec 7.

PMID:
18065961
[PubMed - indexed for MEDLINE]
Free Article
18.

Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management.

Shah RB.

Adv Anat Pathol. 2013 Mar;20(2):117-24. doi: 10.1097/PAP.0b013e3182862ac5. Review.

PMID:
23399797
[PubMed - indexed for MEDLINE]
19.

Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA).

Evren S, Dermen A, Lockwood G, Fleshner N, Sweet J.

Prostate. 2010 Sep 15;70(13):1429-36. doi: 10.1002/pros.21178.

PMID:
20687216
[PubMed - indexed for MEDLINE]
20.

TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation.

Casey OM, Fang L, Hynes PG, Abou-Kheir WG, Martin PL, Tillman HS, Petrovics G, Awwad HO, Ward Y, Lake R, Zhang L, Kelly K.

PLoS One. 2012;7(7):e41668. doi: 10.1371/journal.pone.0041668. Epub 2012 Jul 30.

PMID:
22860005
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk